Jeffrey R. Infante

1 ta ish

Janssen (United States)

1. Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study

   Jesús G. Berdeja, Deepu Madduri, Saad Z. Usmani +33

   Maqola20214 iqtibos

   ABIABI:AkademIndex/2026.other.475845